SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-010825
Filing Date
2020-05-06
Accepted
2020-05-06 16:03:32
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 3-31-2020 form10q.htm   iXBRL 10-Q 2057922
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 13473
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 13354
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6642
  Complete submission text file 0001140361-20-010825.txt   9177024

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ions-20200331.xsd EX-101.SCH 45686
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20200331_cal.xml EX-101.CAL 67713
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20200331_def.xml EX-101.DEF 282705
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20200331_lab.xml EX-101.LAB 708421
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20200331_pre.xml EX-101.PRE 396029
21 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 2031942
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 20852555
SIC: 2834 Pharmaceutical Preparations